Is there any supportive evidence for low dose radiotherapy for COVID-19 pneumonia?
- 2 October 2020
- journal article
- review article
- Published by Taylor & Francis in International Journal of Radiation Biology
- Vol. 96 (10) , 1228-1235
Abstract
Since early April 2020, there has been intense debate over proposed clinical use of ionizing radiation to treat life-threatening pneumonia in Coronavirus Disease 2019 (COVID-19) patients. At least twelve relevant papers appeared by 20 May 2020. The radiation dose proposed for clinical trials are a single dose (0.1-1 Gy) or two doses (a few mGy followed by 0.1-0.25 Gy involving a putative adaptive response, or 1-1.5 Gy in two fractions 2-3 days apart). The scientific rationale for such proposed so-called low dose radiotherapy (LDRT) is twofold (note that only doses below 0.1 Gy are considered as low doses in the field of radiation protection, but here we follow the term as conventionally used in the field of radiation oncology). Firstly, the potentially positive observations in human case series and biological studies in rodent models on viral or bacterial pneumonia that were conducted in the pre-antibiotic era. Secondly, the potential anti-inflammatory properties of LDRT, which have been seen when LDRT is applied locally to subacute degenerative joint diseases, mainly in Germany. However, the human and animal studies cited as supportive evidence have significant limitations, and whether LDRT produces anti-inflammatory effects in the inflamed lung or exacerbates ongoing COVID-19 damage remains unclear. Therefore, we conclude that the available scientific evidence does not justify clinical trials of LDRT for COVID-19 pneumonia, with unknown benefit and known mortality risks from radiogenic cancer and circulatory disease. Despite the significant uncertainties in these proposals, some clinical trials are ongoing and planned. This paper gives an overview of current situations surrounding LDRT for COVID-19 pneumonia.Keywords
This publication has 45 references indexed in Scilit:
- Low-Dose Gamma Radiation Does Not Induce an Adaptive Response for Micronucleus Induction in Mouse SplenocytesRadiation Research, 2015
- Radiotherapy for non-malignant disorders: state of the art and update of the evidence-based practice guidelinesBritish Journal of Radiology, 2015
- Potential Increased Risk of Ischemic Heart Disease Mortality With Significant Dose Fractionation in the Canadian Fluoroscopy Cohort StudyAmerican Journal of Epidemiology, 2013
- Systematic Review and Meta-analysis of Circulatory Disease from Exposure to Low-Level Ionizing Radiation and Estimates of Potential Population Mortality RisksEnvironmental Health Perspectives, 2012
- Risks Associated with Low Doses and Low Dose Rates of Ionizing Radiation: Why Linearity May Be (Almost) the Best We Can DoRadiology, 2009
- Variability: The common factor linking low dose-induced genomic instability, adaptation and bystander effectsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2007
- Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesisThe Journal of Pathology, 2004
- Effects of Inhaled 144CeO2, on Influenza Virus Infection in MiceExperimental Biology and Medicine, 1973
- Effect of Roentgen Therapy on Mouse EncephalitisRadiology, 1949
- A COMPARISON OF THE EFFECTS OF X-RAY AND DRY HEAT ON ANTIBODY FORMATIONJournal of Experimental Medicine, 1925